Original Article Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients
|
|
- Peter Stevenson
- 5 years ago
- Views:
Transcription
1 Int J Clin Exp Pathol 2015;8(7): /ISSN: /IJCEP Original Article Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients Yongkai Wu 1, Bo Huang 2, Qian Liu 2, Yongyu Liu 1 1 Department of Thoracic Surgery, Liaoning Cancer Hospital & Institute, Shenyang , China; 2 Department of Pathology, Liaoning Cancer Hospital & Institute, Shenyang , China Received May 5, 2015; Accepted June 23, 2015; Epub July 1, 2015; Published July 15, 2015 Abstract: Heat shock protein 90-beta (Hsp90-β) is associated with cell proliferation, differentiation and apoptosis and has been investigated as a prognostic factor in many cancers. However, Hsp90-β protein expression in lung adenocarcinoma (ADC) has not been thoroughly elucidated. The aim of this study was to determine the relationship between Hsp90-β expression, clinicopathological parameters and prognosis in lung adenocarcinomas. Seventy-five surgically resected lung adenocarcinomas and matched normal lung tissue samples were obtained to construct a tissue microarray (TMA), including 44 stage IA-IB cases. Then, Hsp90-β protein expression level in lung tissue was evaluated by immunohistochemistry. Kaplan-Meier survival analysis with a Log-rank significance test was used to estimate the survival differences among subgroups according to Hsp90-β expression in lung ADC tissues using SigmaPlot/SigmaStat v10 and 3.5, respectively. Hsp90-β protein expression was significantly upregulated in lung ADC tissues compared to that in the matched normal alveoli (P<0.001) and was associated with tumor differentiation (P<0.001). Furthermore, Hsp90-β over-expression was correlated with poor survival in stage I patients (P=0.026). Increased Hsp90-β expression was associated with reduced overall survival (HR, 2.440; 95% confidence interval, ; P=0.033). To conclude, our data demonstrated that Hsp90-β protein was over-expressed in lung ADC tumor tissues and was associated with poor outcomes in early stage ADC patients and low pathological grade tumors. These data suggest that Hsp90-β could be a clinically useful biomarker for the prognosis of ADC and an effective anticancer target. Keywords: Lung adenocarcinoma, Hsp90-beta, survival, early stage, anticancer target Introduction According to an annual report regarding the prevalence of cancer in China in 2010, lung cancer has become one of the most serious threats to human health in both urban and rural areas. Its incidence and mortality are listed first among a variety of tumors [1]. Approximately 50% of patients are diagnosed at late stages, leading to poor prognoses. The 5-year survival rates of patients with resected stage I nonsmall cell lung cancer (NSCLC) are as high as 50-70% [2]. Therefore, early detection and early cancer treatment are effective methods for reducing cancer mortality and morbidity. Histologically, adenocarcinoma (ADC) is the most prevalent type of lung cancer, accounting for almost half of all of the different types of lung cancers diagnosed [3]. More lung adenocarcinoma cases occur in non-smokers due to the decrease in smoking rates. According to a recent comprehensive molecular profiling study, high rates of somatic mutation were observed in lung ADC tumors, with human epidermal growth factor receptor (EGFR) mutations being more frequent in females and RBM10 mutations being more prevalent in male patients [4]. Heat shock proteins (Hsps) are evolutionarily conserved proteins. One member of the Hsp family is Hsp90, a highly abundant protein in eukaryotic cells that is involved in many important cellular processes. Hsp90-α and Hsp90-β are the two major isoforms of Hsp90 that are associated with cell proliferation, differentiation and apoptosis [5]. In normal conditions,
2 Table 1. Clinicopathological features of lung adenocarcinomas (n=75) Groups Characteristics Number (%) Gender Male 43 (57.3) Hsp90-β has a higher expression level than Hsp90-α in most cells. Furthermore, Hsp90-β plays an important role in early embryonic development and trophoblast differentiation; Hsp90-β-deficient mice failed to differentiate to form placental labyrinths [6, 7]. It has been reported that Hsp90 over-expression in many types of tumors is significantly associated with decreased cancer survival in breast cancer, non-small cell lung cancer, gastric cancer, and conjunctival melanoma, suggesting that Hsp90 participates in tumorigenesis [8-11]. However, Hsp90-β protein expression in lung ADC has not been thoroughly elucidated. In this study, we identified the expression profile of the Hsp90-β protein in lung ADC tissue by TMA. We further investigated whether Hsp90-β upregulation is associated with lung cancer clinicopathological parameters and evaluated the potential use of Hsp90-β as a prognostic marker for lung ADC. Methods Female 32 (42.7) Age <60 39 (52.0) (48.0) Histology Acinar predominant adenocarcinoma, APA 31 (41.3) Papillary predominant adenocarcinoma, PPA 20 (26.6) Solid predominant adenocarcinoma, SPA 13 (17.3) Micropapillary predominant adenocarcinoma, MPA 2 (2.7) Lepidic predominant adenocarcinoma, LPA 1 (1.3) Invasive mucinous adenocarcinoma 5 (6.7) Fetal invasive adenocarcinoma 1 (1.3) Enteric invasive adenocarcinoma 2 (2.7) Pathologic grade Well-differentiated 19 (25.3) Moderately differentiated 27 (36.0) Poorly differentiated 24 (32.0) Undifferentiated 5 (6.7) TNM staging IA-IB 44 (58.7) IIA-IIB 28 (37.3) IIIA-IIIB 3 (4.0) Clinical samples and histopathologic data The 75 patients with primary lung adenocarcinoma included in this study underwent conventional radical tumor resections between July 2005 and December 2011 at the Liaoning Cancer Hospital & Institute, China. All of the patients provided informed consent. Lung cancer and matched normal tissue specimens were formalin-fixed and paraffin-embedded. There were 43 male and 32 female patients, who ranged in age from 32 to 80 years (median 59 years). Tumor stage was classified according to the 7th Union International Cancer Control (UICC) TNM staging system. There were 44 stage IA-IB patients, 28 stage IIA- IIB patients and 3 stage IIIA-IIIB patients. The ADCs were classified according to the International association for the study of cancer/american thoracic society/european respiratory society (IASLC/ATS/ERS) classification. The following major lung ADC histological types were represented: (1) 41.3% acinar, (2) 26.6% papillary, (3) 2.7% micropapillary, (4) 17.3% solid, (5) 1.3% lepidic, (6) 6.7% invasive mucinous, (7) 1.3% fetal and (8) 2.7% enteric adenocarcinomas (Table 1). Follow-up The patients had follow-up appointments every 3 months for the first year after surgery, every 6 months for the second year and then yearly thereafter. The follow-up deadline was June The median follow-up period was 24 months (ranging from 2-95 months), and 40 patients were alive at the time of the last follow-up. Tissue microarray (TMA) construction and immunohistochemistry staining The formalin-fixed and paraffin-embedded lung cancer and matched normal tissue samples were obtained from surgery. Before the construction of the tissue microarray (TMA), a pathologist reviewed the H&E stained slides and the localized tumor/normal areas. Briefly, a tissue core from the donor block was punched 8253 Int J Clin Exp Pathol 2015;8(7):
3 using a hollow needle with an inner diameter of 1.5 mm. Then, the samples from each tissue were precisely placed into a recipient block at specifically assigned locations. The array block was baked in an oven and tested with H&E staining and an immunohistochemistry (IHC) test. IHC staining was performed using a standard streptavidin-biotin-peroxidase complex method as described previously [11]. TMA sections (5 m thick) were incubated at 4 C in a humid chamber overnight with a rabbit polyclonal antibody against human Hsp90-β (1:100, ABGENT, catalog #AP7867d, San Diego, CA, USA). PBS was used as a negative control. The nuclei were counterstained with hematoxylin. Two experienced pathologists independently scored the immunostaining results. The immunoreactivity scoring (IRS) criteria were graded according to the following scale [12]: (1) 0, no staining; (2) 1+, weak diffuse cytoplasmic staining (with stronger staining in <25% of the cells); (3) 2, moderate cytoplasmic staining in 25-50% of the cells; and (4) 3, intense staining in >50% of the cells. The samples ranked as IRS 0 and 1 were defined as low Hsp90-β expressers, IRS 2 as moderate Hsp90-β expressers, and IRS3 as high Hsp90-β expressers. Western blot Twenty four paired fresh cancer tissues and adjacent normal tissues were collected from May 2010 to December 2011, and the total protein was extracted. In all samples, 30 μg of total protein was loaded on a 10% SDS-PAGE gel and electrophoretically separated. The proteins were transferred to polyvinylidene difluoride membranes according to the routine protocol. The membranes were incubated with rabbit polyclonal antibody against human Hsp90-β (ABGENT, catalog #AP7867d, San Diego, CA, USA) at a dilution of 1:1000 overnight at 4 C. The primary antibodies were detected using horseradish peroxidase-conjugated secondary antibodies, the membrane were detected with the enhanced chemiluminescence method. And β-actin was used as a control for equivalent protein loading. Statistical analysis The associations between the expression status and clinicopathological parameters were analyzed using the chi-square test. Kaplan- Meier survival analysis with the Log-rank significance test was used to estimate the survival differences among various subgroups according to HSP90-β expression in lung ADC tissues using SigmaPlot/SigmaStat v10 and 3.5, respectively (Systat Software, San Jose, CA, USA). The significance level was defined as P<0.05. Results Expression of Hsp90-β in lung cancer and normal tissues Seventy-five lung ADC tissue samples were examined by immunohistochemistry. Hsp90-β staining was predominantly located in the cytoplasm of the tumor cells. According to the IRS criteria, the expression intensities of Hsp90-β immunostaining were low (IRS0, 1), moderate (IRS2), and high (IRS3), as shown in Figure 1. Correlations between the clinicopathological features and Hsp90-β expression in lung adenocarcinoma are summarized in Table 2. The IHC results showed that moderate and high Hsp90-β protein expression was observed in 82.7% (62/75) of lung cancer samples, and almost no or low expression (75/75, 100.0%) was observed in the matched normal alveoli. In addition, Hsp90-β expression was markedly associated with tumor grade. The expression frequencies of Hsp90-β in the poorly-differentiated tumors were considerably higher than those detected in the well-differentiated tumors (45.8%, 34.6% and 0.0% expression for poorly, moderately and well-differentiated tumors, respectively, P<0.001). However, Hsp90-β expression did not correlate with other clinicopathologic factors, such as gender, age, histology, TNM stage, and lymph node metastasis. The Western blot results indicated high expression levels of Hsp90-β in the cancer tissues than the adjacent normal tissues (P<0.001, Figure 2). Association of high levels of Hsp90-β protein in tumor tissue with poor prognosis in early stage patients Overall survival (OS) was calculated from the date of surgery to the date of death or the last follow-up. Unexpectedly, there was no significant relationship between Hsp90-β expression levels and the prognosis of lung ADC patients. However, we further investigated the association between Hsp90-β expression levels and 8254 Int J Clin Exp Pathol 2015;8(7):
4 Figure 1. Hsp90-β protein expression in lung ADC tissues as observed by immunohistochemical staining with a rabbit polyclonal antibody against Hsp90-β applied to formalin-fixed and paraffin-embedded tissues in the manner of tissue microarrays. A. The expression intensity of Hsp90-β immunostaining in normal alveoli was IRS0; B-D. The expression intensities of Hsp90-β immunostaining in lung ADCs were IRS01, IRS2, and IRS3, respectively. early stage lung ADC patient prognosis. There were 44 early stage (IA-IB) patients. The median follow-up period was 22 months (ranging from 2-95 months), and 20 patients were alive at the time of the last follow-up. The Kaplan- Meier survival analysis revealed that the patients with high (n=16) Hsp90-β expression had a significantly poorer outcome than those with moderate (n=20) or low (n=8) Hsp90-β expression (P=0.034) (Figure 3). The postoperative median OS of the patients with high, moderate and low staining were 22 months, 27 months, and 50 months, respectively. Furthermore, to evaluate the independent impact of Hsp90-β over-expression on OS, a 8255 Int J Clin Exp Pathol 2015;8(7):
5 Table 2. Correlation between clinicopathological features and Hsp90-β expression in lung adenocarcinomas Groups Characteristics N Expression of Hsp90-beta Low (%) Moderate (%) High (%) χ 2 value P value Gender Male 43 7 (16.3) 23 (53.5) 13 (30.2) Female 32 6 (18.8) 19 (59.4) 7 (21.9) Age < (20.5) 21 (53.8) 10 (25.6) (13.9) 21 (58.3) 10 (27.8) Histology APA 31 6 (19.4) 17 (54.8) 8 (25.8) PPA 20 4 (20.0) 9 (45.0) 7 (35.0) SPA 13 1 (7.7) 7 (53.8) 5 (38.5) Others# 11 2 (18.2) 9 (81.8) 0 (0.0) Pathologic grade Well (47.8) 12 (52.2) 0 (0.0) <0.001 Moderate 26 2 (7.7) 15 (57.7) 9 (34.6) Poor 24 0 (12.5) 13 (54.2) 11 (33.3) Undifferentiated 2 0 (0.0) 2 (100.0) 0 (0.0) TNM staging I 44 8 (18.2) 20 (45.6) 16 (36.4) II+III 31 5 (16.1) 22 (71.0) 4 (12.9) Lymph node metastasis N (16.7) 25 (52.1) 15 (31.3) N (18.5) 17 (63.0) 5 (18.5) APA, Acinar predominant adenocarcinoma; PPA, Papillary predominant adenocarcinoma; SPA, Solid predominant adenocarcinoma. #, others including Micropapillary predominant adenocarcinoma, Lepidic predominant adenocarcinoma, Invasive mucinous adenocarcinoma, Fetal invasive adenocarcinoma, and Enteric invasive adenocarcinoma. factor for OS (Hazard ratios, 2.440; 95% confidence interval, ; P=0.033) for early stage lung ADC cancer patients (Table 3). Discussion Figure 2. Protein expression of Hsp90-β in lung ADC tissues was detected by Western blotting. A. Hsp90-β expression in paired normal (N) and tumor (T) tissues of 24 ADC patients. B. The Western blot results indicated high expression levels of Hsp90-beta in the cancer tissues than the adjacent normal tissues (P<0.001). multivariate Cox s proportional hazards regression model adjusted for age, gender, histology, pathologic grade and Hsp90-β expression was performed. Our results showed that Hsp90-β expression was an independent prognostic The incidence rates of lung adenocarcinoma are increasing rapidly in most countries among males and females and account for approximately 85% of non-small cell lung cancer (NSCLC) [13]. The highly conserved Hsp90, comprising 1-2% of cellular proteins, acts as an essential cytoplasmic chaperone complex and is involved in maintaining homeostasis by assisting protein folding [5]. In this study, the relationship between Hsp90-β expression and clinicopathological factors was evaluated. We observed that Hsp90-β was commonly overexpressed in lung ADC, even in very early stage (IA-IB) patients. By multivariate analysis, high levels of Hsp90-β expression remained an independent factor for overall survival in stage I ADC patients. More importantly, our data suggest that Hsp90-β over-expression was associated with high pathologic grade lung ADC. Targeted therapy is currently available for lung ADC. The frequency of the EGFR (epidermal growth factor receptor) mutation is 15%-20% in 8256 Int J Clin Exp Pathol 2015;8(7):
6 Figure 3. The Kaplan-Meier survival analysis revealed that the patients with high (n=16) Hsp90-β expression had a significantly poorer outcome than those with moderate (n=20) or low (n=8) Hsp90-β expression (P=0.034). Table 3. Multivariate cox regression analysis for overall survival in early stage patients with lung ADC cancer Variable Overall survival (n=44) Hazard ratios (95% CI) P value Age ( ) Gender ( ) Histology ( ) Pathologic grade ( ) Hsp90-beta ( ) CI, confidence interval. white populations and over 50% in Asian patients with ADC [14]. Hsp90 binds some important transcription factor and signaling molecule gene promoters, such as c-myc, p53, scr, and rhomboid (rho) [15]. Furthermore, rho codes for a component the triggers the EGF pathway in Drosophila adult muscle precursors (AMPs), suggesting that Hsp90 is also implicated in the EGFR pathway [16]. The Hsp90 N-terminus contains an ATPbinding domain, which is important for its cellular functions [17]. Several Hsp- 90 inhibitors that are used to target cancers by inhibiting Hsp90 s ATPase activity have been successfully evaluated in clinical trials, for example, geldanamycin [18]. A recent study reported that combining a proteasome inhibitor with an Hsp90 antagonist might represent a novel strategy against NSCLC (non-small cell lung cancer) [19]. In our cohort study, Hsp90-β was significantly increased in 82.7% of lung ADC samples compared to that of normal alveoli and was associated with poor outcome in stage I patients after surgery. These clinical studies suggest that Hsp90 is an effective anticancer target [20]. In our study, significantly increased levels of Hsp90-β were detected in poorly differentiated lung ADC tis- sues, suggesting that Hsp70-β over-expression is responsible for the differentiation of lung ADC cells. It has been reported that Hsp90-β inhibits cell differentiation by preventing autoubiquitination and the degradation of its client protein, cellular inhibitor of apoptosis protein-1 (c-iap1) [21]. The ubiquitin protein ligase activity of c-iap1 regulates the tumor necrosis factor alpha (TNF-α) signaling pathway by expressing tumor necrosis factor receptor 2 (TNFR2) [22]. Hsp90 inhibitors have been shown to block cell differentiation [23]. Retaspimycin hydrochloride (IPI-504), one of the inhibitors, is in clinical trials for NSCLC patients ( Trial.gov). Furthermore, IPI-504 induced cell apoptosis and blocked the migration and invasion of high-grade gliomas (HGGs), indicating that IPI-450 could be a therapeutic strategy for gliomas [24]. In conclusion, our results show that Hsp90-β exhibited high expression levels in lung ADC tissues, particularly in poorly differentiated 8257 Int J Clin Exp Pathol 2015;8(7):
7 lung cancer. Additionally, increased Hsp90-β levels were an independent predictor of worse prognosis. Acknowledgements This work was supported by the Natural Science Foundation of Liaoning Province ( ). Disclosure of conflict of interest None. Address correspondence to: Dr. Yongyu Liu, Department of Thoracic Surgery, Liaoning Cancer Hospital & Institute, 44 Xiaoheyan Road, Dadong District, Shenyang , China. Tel: ; References [1] Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X, He J. Annual report on status of cancer in China, Chin J Cancer Res 2014; 26: [2] Hung JJ, Jeng WJ, Hsu WH, Chou TY, Huang BS, Wu YC. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-i non-small-cell lung cancer. J Thorac Oncol 2012; 7: [3] Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011; 6: [4] Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature 2014; 511: [5] Sreedhar AS, Kalmár E, Csermely P, Shen YF. Hsp90 isoforms: functions, expression and clinical importance. FEBS Lett 2004; 562: [6] Gruppi CM, Zakeri ZF, Wolgemuth DJ. Stage and lineage-regulated expression of two hsp90 transcripts during mouse germ cell differentiation and embryogenesis. Mol Reprod Dev 1991; 28: [7] Voss AK, Thomas T, Gruss P. Mice lacking HSP90beta fail to develop a placental labyrinth. Development 2000; 127: [8] Pick E, Kluger Y, Giltnane JM, Moeder C, Camp RL, Rimm DL, Kluger HM. High HSP90 expression is associated with decreased survival in breast cancer. Cancer Res 2007; 67: [9] Liu W, Wu Y, Wang L, Gao L, Wang Y, Liu X, Zhang K, Song J, Wang H, Bayer TA, Glaser L, Sun Y, Zhang W, Cutaia M, Zhang DY, Ye F. Protein signature for non-small cell lung cancer prognosis. Am J Cancer Res 2014; 4: [10] Westekemper H, Karimi S, Süsskind D, Anastassiou G, Freistühler M, Steuhl KP, Bornfeld N, Schmid KW, Grabellus F. Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma. Br J Ophthalmol 2011; 95: [11] Wang J, Cui S, Zhang X, Wu Y, Tang H. High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer. PLoS One 2013; 8: e [12] Li M, Xiao T, Zhang Y, Feng L, Lin D, Liu Y, Mao Y, Guo S, Han N, Di X, Zhang K, Cheng S, Gao Y. Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients. Lung Cancer 2010; 69: [13] Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005; 117: [14] Shi Y, Au JS, Thongprasert S, Srinivasan S, Tsai CM, Khoa MT, Heeroma K, Itoh Y, Cornelio G, Yang PC. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER). J Thorac Oncol 2014; 9: [15] Sawarkar R, Sievers C, Paro R. Hsp90 globally targets paused RNA polymerase to regulate gene expression in response to environmental stimuli. Cell 2012; 149: [16] Figeac N, Jagla T, Aradhya R, Da Ponte JP, Jagla K. Drosophila adult muscle precursors form a network of interconnected cells and are specified by the rhomboid-triggered EGF pathway. Development 2010; 137: [17] Taipale M, Jarosz DF, Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 2010; 11: [18] Barrott JJ, Haystead TA. Hsp90, an unlikely ally in the war on cancer. FEBS J 2013; 280: [19] Zismanov V, Drucker L, Gottfried M. Combined inhibition of hsp90 and the proteasome af Int J Clin Exp Pathol 2015;8(7):
8 fects NSCLC proteostasis and attenuates cell migration. Anticancer Drugs 2014; 25: [20] Workman P, Burrows F, Neckers L, Rosen N. Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann N Y Acad Sci 2007; 1113: [21] Didelot C, Lanneau D, Brunet M, Bouchot A, Cartier J, Jacquel A, Ducoroy P, Cathelin S, Decologne N, Chiosis G, Dubrez-Daloz L, Solary E, Garrido C. Interaction of heat-shock protein 90 beta isoform (HSP90 beta) with cellular inhibitor of apoptosis 1 (c-iap1) is required for cell differentiation. Cell Death Differ 2008; 15: [22] Zhao Y, Conze DB, Hanover JA, Ashwell JD. Tumor necrosis factor receptor 2 signaling induces selective c-iap1-dependent ASK1 ubiquitination and terminates mitogen-activated protein kinase signaling. J Biol Chem 2007; 282: [23] Yun BG, Matts RL. Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation. Exp Cell Res 2005; 307: [24] Di K, Keir ST, Alexandru-Abrams D, Gong X, Nguyen H, Friedman HS, Bota DA. Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models. J Neurooncol 2012; 40: Int J Clin Exp Pathol 2015;8(7):
Classification of non-small cell lung carcinomas (NSCLC)
Classification of non-small cell lung carcinomas (NSCLC) 1. NordiQC Conference on Standardization in Applied Immunohistochemistry 4-7 June 2013 Birgit Guldhammer Skov, MD. DMeSci, Dept. Of Pathology, Rigshospitalet,
More informationMOLECULAR PREDICTIVE MARKERS OF LUNG CARCINOMA: KFSH&RC EXPERIENCE
25 th IAP-Arab Division Conference 07-09 November 2013, Amman, Jordan MOLECULAR PREDICTIVE MARKERS OF LUNG CARCINOMA: KFSH&RC EXPERIENCE Fouad Al Dayel, MD, FRCPA, FRCPath Professor and Chairman Department
More informationPrognostic factors in curatively resected pathological stage I lung adenocarcinoma
Original Article Prognostic factors in curatively resected pathological stage I lung adenocarcinoma Yikun Yang 1, Yousheng Mao 1, Lin Yang 2, Jie He 1, Shugeng Gao 1, Juwei Mu 1, Qi Xue 1, Dali Wang 1,
More informationOriginal Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome
Int J Clin Exp Pathol 2017;10(2):2030-2035 www.ijcep.com /ISSN:1936-2625/IJCEP0009456 Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical
More informationHigh expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.
Biomedical Research 2017; 28 (18): 7779-7783 ISSN 0970-938X www.biomedres.info High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer. Hu Song 1, Qi-yu Liu 2, Zhi-wei
More informationPulmonary adenocarcinoma Issues, Issues and more issues. Why the headache?
Issues Pulmonary adenocarcinoma Issues, Issues and more issues. Why the headache? Classification Multiple nodules Invasive size Alain Borczuk, MD Weill Cornell Medicine Chronic headache - Classification
More informationMinor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis
Ann Surg Oncol (2016) 23:2099 2105 DOI 10.1245/s10434-015-5043-9 ORIGINAL ARTICLE THORACIC ONCOLOGY Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph
More informationOriginal Article Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification of lung adenocarcinoma
Int J Clin Exp Pathol 2014;7(11):8039-8045 www.ijcep.com /ISSN:1936-2625/IJCEP0002211 Original Article Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationLung cancer is now a major cause of death in developed
Original Article New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma Naoki Yanagawa, MD, PhD,* Satoshi Shiono, MD, PhD, Masami Abiko,
More informationCharacterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma
Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department
More informationExtent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer Yangki Seok 1, Ji Yun Jeong 2 & Eungbae
More informationResearch Article Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically Resected Lung Adenocarcinoma
BioMed Research International, Article ID 64568, 6 pages http://dx.doi.org/.55/24/64568 Research Article Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically
More informationORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery
Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji
More informationCirculating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics Jie Zhang, Jing Gao, Yanyan
More informationPD-L1 Expression in Non-Small-Cell Lung Cancer Including Various Adenocarcinoma Subtypes
doi: 10.5761/atcs.oa.18-00163 Original Article PD-L1 Expression in Non-Small-Cell Lung Cancer Including Various Adenocarcinoma Subtypes Tomoyuki Miyazawa, MD, 1 Hideki Marushima, MD, PhD, 1 Hisashi Saji,
More informationOriginal Article Thymidine kinase 1 is a better prognostic marker than Ki-67 for pt1 adenocarcinoma of the lung
Int J Clin Exp Med 2014;7(8):2120-2128 www.ijcem.com /ISSN:1940-5901/IJCEM1402040 Original Article Thymidine kinase 1 is a better prognostic marker than Ki-67 for pt1 adenocarcinoma of the lung Yan Xu
More informationExpression and clinical significance of ADAM17 protein in esophageal squamous cell carcinoma
Expression and clinical significance of ADAM17 protein in esophageal squamous cell carcinoma H.B. Liu, Y. Zhu, Q.C. Yang, Y. Shen, X.J. Zhang and H. Chen Department of Pathology First People s Hospital
More informationPrognostic significance of nemo like kinase in nasopharyngeal carcinoma
MOLECULAR MEDICINE REPORTS 10: 131-136, 2014 Prognostic significance of nemo like kinase in nasopharyngeal carcinoma SIZE CHEN 1,2*, ZHIJIAN MA 3*, XUEMEI CHEN 4 and JIREN ZHANG 1 1 Department of Oncology,
More informationONCOLOGY LETTERS 8: , 2014
ONCOLOGY LETTERS 8: 813-818, 2014 Investigation of the epidermal growth factor receptor mutation rate in non small cell lung cancer patients and the analysis of associated risk factors using logistic regression
More informationShould minimally invasive lung adenocarcinoma be transferred from stage IA1 to stage 0 in future updates of the TNM staging system?
Original Article Should minimally invasive lung adenocarcinoma be transferred from stage to stage 0 in future updates of the TNM staging system? Tianxiang Chen 1,2#, Jizhuang Luo 3#, Haiyong Gu 3, Yu Gu
More informationExpression of long non-coding RNA linc-itgb1 in breast cancer and its influence on prognosis and survival
European Review for Medical and Pharmacological Sciences 2017; 21: 3397-3401 Expression of long non-coding RNA linc-itgb1 in breast cancer and its influence on prognosis and survival W.-X. LI 1, R.-L.
More informationAccepted Manuscript. Risk stratification for distant recurrence of resected early stage NSCLC is under construction. Michael Lanuti, MD
Accepted Manuscript Risk stratification for distant recurrence of resected early stage NSCLC is under construction Michael Lanuti, MD PII: S0022-5223(17)32392-9 DOI: 10.1016/j.jtcvs.2017.10.063 Reference:
More informationRatio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer
Original Article Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer Fangfang Chen 1 *, Yanwen Yao 2 *, Chunyan
More informationOriginal Article Cullin1 is up-regulated and associated with poor patients survival in hepatocellular carcinoma
Int J Clin Exp Pathol 2015;8(4):4001-4007 www.ijcep.com /ISSN:1936-2625/IJCEP0006288 Original Article Cullin1 is up-regulated and associated with poor patients survival in hepatocellular carcinoma Wen
More informationCorrelation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients
1568 Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients LIYING GUO 1, YU ZHANG 2, WEI ZHANG 3 and DILIMINA YILAMU 1 1 Department of
More informationThe histological grading of lung cancer is a significant
ORIGINAL ARTICLE Interobserver Agreement in the Nuclear Grading of Primary Pulmonary Adenocarcinoma Yoshimasa Nakazato, MD,* Akiko Miyagi Maeshima, MD, Yuichi Ishikawa, MD, Yasushi Yatabe, MD, Junya Fukuoka,
More informationPredictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer
Original Article Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer Feichao Bao, Ping Yuan, Xiaoshuai Yuan, Xiayi Lv, Zhitian Wang, Jian Hu Department
More informationLung cancer continues to be the leading cause of cancer
original article Why Do Pathological Stage IA Lung Adenocarcinomas Vary from Prognosis? A Clinicopathologic Study of 176 Patients with Pathological Stage IA Lung Adenocarcinoma Based on the IASLC/ATS/ERS
More informationStudy on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value
Study on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value Shen Wei 1,a, Chen Juan 2, Li Xiurong 1 and Yin Jie 1 1 Department of Obstetrics and Gynecology,
More informationSecond predominant subtype predicts outcomes of intermediatemalignant invasive lung adenocarcinoma
European Journal of Cardio-Thoracic Surgery 51 (2017) 218 222 doi:10.1093/ejcts/ezw318 Advance Access publication 6 October 2016 ORIGINAL ARTICLE Cite this article as: Ito M, Miyata Y, Yoshiya T, Tsutani
More informationOriginal Article Tissue expression level of lncrna UCA1 is a prognostic biomarker for colorectal cancer
Int J Clin Exp Pathol 2016;9(4):4241-4246 www.ijcep.com /ISSN:1936-2625/IJCEP0012296 Original Article Tissue expression level of lncrna UCA1 is a prognostic biomarker for colorectal cancer Hong Jiang,
More informationThe new international multidisciplinary lung adenocarcinoma
Eur Respir J 2011; 38: 239 243 DOI: 10.1183/09031936.00026711 CopyrightßERS 2011 EDITORIAL Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification W.D. Travis*,"",
More informationSOLITARY PULMONARY NODULES
SOLITARY PULMONARY NODULES Histological subtypes of solitary pulmonary nodules of adenocarcinoma and their clinical relevance Hui-Di Hu 1*, Ming-Yue Wan 1*, Chun-Hua Xu 2,3, Ping Zhan 2,3, Jue Zou 1, Qian-Qian
More informationLow levels of serum mir-99a is a predictor of poor prognosis in breast cancer
Low levels of serum mir-99a is a predictor of poor prognosis in breast cancer J. Li 1, Z.J. Song 2, Y.Y. Wang 1, Y. Yin 1, Y. Liu 1 and X. Nan 1 1 Tumor Research Department, Shaanxi Provincial Tumor Hospital,
More informationFrequencies of actionable mutations and survival in variants of invasive adenocarcinoma of lung
Original Article Frequencies of actionable mutations and survival in variants of invasive adenocarcinoma of lung Zhengbo Song 1,2 *, Tangfeng Lv 1 *, Yiping Zhang 2, Yong Song 1 1 Department of Respiratory
More informationOnly Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationP atients with primary breast cancer have an increased risk of developing contralateral breast cancer1. When
OPEN SUBJECT AREAS: BONE METASTASES BREAST CANCER Received 23 July 2013 Accepted 19 August 2013 Published 5 September 2013 Correspondence and requests for materials should be addressed to C.W.D. (ducaiwen@
More informationTHE IASLC/ERS/ATS ADENOCARCINOMA CLASSIFICATION RATIONALE AND STRENGTHS
THE IASLC/ERS/ATS ADENOCARCINOMA CLASSIFICATION RATIONALE AND STRENGTHS PULMONARY PATHOLOGY SOCIETY USCAP, BALTIMORE, March 2, 2013 William D. Travis, M.D. Dept of Pathology, Memorial Sloan-Kettering Cancer
More informationOverexpression of long-noncoding RNA ZFAS1 decreases survival in human NSCLC patients
European Review for Medical and Pharmacological Sciences 2016; 20: 5126-5131 Overexpression of long-noncoding RNA ZFAS1 decreases survival in human NSCLC patients F.-M. TIAN 1, F.-Q. MENG 2, X.-B. WANG
More informationOriginal Article High serum mir-203 predicts the poor prognosis in patients with pancreatic cancer
Int J Clin Exp Pathol 2017;10(4):4688-4693 www.ijcep.com /ISSN:1936-2625/IJCEP0047128 Original Article High serum mir-203 predicts the poor prognosis in patients with pancreatic cancer Jun Ma, Xiaokun
More informationAnalysis of Prognosis and Prognostic Factors of Cervical Adenocarcinoma and Adenosqumous Carcinoma of the Cervix
DOI 10.1007/s11805-009-0133-8 133 Analysis of rognosis and rognostic Factors of Cervical Adenocarcinoma and Adenosqumous Carcinoma of the Cervix Guangwen Yuan Lingying Wu Xiaoguang Li Manni Huang Department
More informationTitle: Synuclein Gamma Predicts Poor Clinical Outcome in Colon Cancer with Normal Levels of Carcinoembryonic Antigen
Author's response to reviews Title: Synuclein Gamma Predicts Poor Clinical Outcome in Colon Cancer with Normal Levels of Carcinoembryonic Antigen Authors: Caiyun Liu (liucaiyun23@yahoo.com.cn) Bin Dong
More informationOriginal Article Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer
Int J Clin Exp Pathol 2015;8(3):2937-2945 www.ijcep.com /ISSN:1936-2625/IJCEP0005254 Original Article Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer Jian-Zhong Liang
More informationMutation and prognostic analyses of PIK3CA in patients with completely resected lung adenocarcinoma
Cancer Medicine ORIGINAL RESEARCH Open Access Mutation and prognostic analyses of PIK3CA in patients with completely resected lung adenocarcinoma Zhengbo Song 1,2, Xinmin Yu 1 & Yiping Zhang 1,2 1 Department
More informationQuality ID #395: Lung Cancer Reporting (Biopsy/Cytology Specimens) National Quality Strategy Domain: Communication and Care Coordination
Quality ID #395: Lung Cancer Reporting (Biopsy/Cytology Specimens) National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE:
More informationLong non-coding RNA Loc is a potential prognostic biomarker in non-small cell lung cancer
European Review for Medical and Pharmacological Sciences 2017; 21: 3808-3812 Long non-coding RNA Loc344887 is a potential prognostic biomarker in non-small cell lung cancer B. WU 1, X.-J. ZHANG 2, X.-G.
More informationPositive nin one binding protein expression predicts poor outcome in prostate cancer
MOLECULAR MEDICINE REPORTS 11: 2671-2676, 2015 Positive nin one binding protein expression predicts poor outcome in prostate cancer JIE CHEN *, JUNKAI WANG *, XINGANG CUI, YUSHAN LIU, LEI YIN, YAO LI,
More informationDiscrimination of Clinical Stages in Lung Cancer Patients by Serum HSP27 and HSP70
Discrimination of Clinical Stages in Lung Cancer Patients by Serum HSP27 and HSP70 Diplomarbeit Zimmermann Matthias ausgeführt an der Universitätsklinik für Chirurgie Christian Doppler Laboratory for Cardiac
More informationPleomorphic carcinoma of the lung: which CT findings predict poor prognosis?
Pleomorphic carcinoma of the lung: which CT findings predict poor prognosis? Poster No.: C-1887 Congress: ECR 2015 Type: Scientific Exhibit Authors: A. Fujisaki, T. Aoki, S. Kinoshita, Y. Hayashida, Y.
More informationSupplementary Figure 1. HOPX is hypermethylated in NPC. (a) Methylation levels of HOPX in Normal (n = 24) and NPC (n = 24) tissues from the
Supplementary Figure 1. HOPX is hypermethylated in NPC. (a) Methylation levels of HOPX in Normal (n = 24) and NPC (n = 24) tissues from the genome-wide methylation microarray data. Mean ± s.d.; Student
More informationExon 19 L747P mutation presented as a primary resistance to EGFR-TKI: a case report
Case Report Exon 19 L747P mutation presented as a primary resistance to EGFR-TKI: a case report Yu-Ting Wang, Wei-Wei Ning, Jing Li, Jian-n Huang Department of Respiratory Medicine, the First ffiliated
More informationLong non-coding RNA CCHE1 overexpression predicts a poor prognosis for cervical cancer
European Review for Medical and Pharmacological Sciences 2017; 20: 479-483 Long non-coding RNA CCHE1 overexpression predicts a poor prognosis for cervical cancer Y. CHEN, C.-X. WANG, X.-X. SUN, C. WANG,
More informationAndrogen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target?
Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target? New Frontiers in Urologic Oncology Juan Chipollini, MD Clinical Fellow Department of Genitourinary Oncology Moffitt Cancer
More informationOriginal Article Clinical significance of SOX2 and snail expression in esophageal squamous cell carcinoma
Int J Clin Exp Pathol 2016;9(9):9569-9574 www.ijcep.com /ISSN:1936-2625/IJCEP0027666 Original Article Clinical significance of SOX2 and snail expression in esophageal squamous cell carcinoma Na Miao 1*,
More informationLog odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection
Original Article Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection Mingjian Yang 1,2, Hongdian Zhang 1,2, Zhao Ma 1,2, Lei Gong 1,2, Chuangui Chen
More informationLin Yang 1, Yun Ling 1, Lei Guo 1, Di Ma 2, Xuemin Xue 1, Bingning Wang 1, Junling Li 2, Jianming Ying 1. Original Article.
Original Article Detection of ALK translocation in non-small cell lung carcinoma (NSCLC) and its clinicopathological significance using the Ventana immunohistochemical staining method: a single-center
More informationPrimary lung cancer is the leading cause of cancer mortality
Original Article Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer Mian Xie, MD, PhD,* Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD, Su-Xia Lin, MD, PhD, Zhi-Huang Hu,
More informationExpression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues
[Chinese Journal of Cancer 27:12, 568-573; December Expression 2008]; 2008 and significance Sun Yat-sen of University Bmi-1 and Cancer Ki67 in Center colorectal carcinoma tissues Clinical Research Paper
More informationCircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer
European Review for Medical and Pharmacological Sciences 2018; 22: 3713-3718 CircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer N. LIU 1, J. ZHANG 1, L.-Y. ZHANG 1, L.
More informationThe 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach
The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach Dr. Carol Farver Director, Pulmonary Pathology Pathology and Laboratory Medicine Institute Objectives Discuss
More informationCharacteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases Mei Li & Zhi-xiong Lin Department of Radiation
More informationmir-218 tissue expression level is associated with aggressive progression of gastric cancer
mir-218 tissue expression level is associated with aggressive progression of gastric cancer X.X. Wang 1, S.J. Ge 2, X.L. Wang 2, L.X. Jiang 1, M.F. Sheng 2 and J.J. Ma 2 1 Department of General Surgery,
More informationDecreased expression of mir-490-3p in osteosarcoma and its clinical significance
European Review for Medical and Pharmacological Sciences Decreased expression of mir-490-3p in osteosarcoma and its clinical significance B. TANG, C. LIU, Q.-M. ZHANG, M. NI Department of Orthopedics,
More informationQuality ID #395: Lung Cancer Reporting (Biopsy/Cytology Specimens) National Quality Strategy Domain: Communication and Care Coordination
Quality ID #395: Lung Cancer Reporting (Biopsy/Cytology Specimens) National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE:
More informationOriginal Article Effects of Skp2 expression on the recurrence and prognosis of esophageal squamous cell carcinoma after complete macroscopic resection
Int J Clin Exp Pathol 2016;9(6):6469-6475 www.ijcep.com /ISSN:1936-2625/IJCEP0024054 Original Article Effects of Skp2 expression on the recurrence and prognosis of esophageal squamous cell carcinoma after
More informationRefining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis
5/17/13 Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis Johannes Kratz, MD Post-doctoral Fellow, Thoracic Oncology Laboratory
More informationLung cancer is the main cause of cancer-related death worldwide.
Original Article Prognostic Factors of Survival after Recurrence in Patients with Resected Lung Adenocarcinoma Jung-Jyh Hung, MD, PhD,* Yi-Chen Yeh, MD, Wen-Juei Jeng, MD, Hong-Che Chien, MD,* Yu-Chung
More informationThe Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer
Original Article The Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer Chen Qiu, MD,* Wei Dong, MD,* Benhua Su, MBBS, Qi Liu, MD,* and Jiajun Du, PhD Introduction:
More informationThe effect of delayed adjuvant chemotherapy on relapse of triplenegative
Original Article The effect of delayed adjuvant chemotherapy on relapse of triplenegative breast cancer Shuang Li 1#, Ding Ma 2#, Hao-Hong Shi 3#, Ke-Da Yu 2, Qiang Zhang 1 1 Department of Breast Surgery,
More informationCorrelation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma
Original Article Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma Yingying Miao 1,2 *, Jianya Zhang 1,2 *, Jiawei Zou 1,2, Qingqing
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationExpression of mir-1294 is downregulated and predicts a poor prognosis in gastric cancer
European Review for Medical and Pharmacological Sciences 2018; 22: 5525-5530 Expression of mir-1294 is downregulated and predicts a poor prognosis in gastric cancer Y.-X. SHI, B.-L. YE, B.-R. HU, X.-J.
More informationLung Neoplasia II Resection specimens Pathobasic. Lukas Bubendorf Pathology
Lung Neoplasia II Resection specimens Pathobasic Lukas Bubendorf Pathology Agenda Preneoplastic lesions Histological subtypes of lung cancer Histological patterns of AC Cells of origin and characteristic
More informationExpression of lncrna TCONS_ in hepatocellular carcinoma and its influence on prognosis and survival
European Review for Medical and Pharmacological Sciences 2017; 21: 5655-5660 Expression of lncrna TCONS_00027978 in hepatocellular carcinoma and its influence on prognosis and survival Q. CHEN 1, G.-D.
More informationCorrelation between survivin expression and prognosis in non-small cell lung cancer
Respiratory Medicine (2006) 100, 2220 2226 Correlation between survivin expression and prognosis in non-small cell lung cancer Sükran Atikcan a, Ebru Ünsal a,, Funda Demirag b, Deniz Köksal a, Aydın Yilmaz
More informationDiffering histopathology and prognosis in pulmonary adenocarcinoma at central and peripheral locations
Original Article Differing histopathology and prognosis in pulmonary adenocarcinoma at central and peripheral locations Youngkyu Moon 1, Kyo Young Lee 2, Sook Whan Sung 1, Jae Kil Park 1 1 Department of
More informationBiomedical Research 2017; 28 (21): ISSN X
Biomedical Research 2017; 28 (21): 9497-9501 ISSN 0970-938X www.biomedres.info Analysis of relevant risk factor and recurrence prediction model construction of thyroid cancer after surgery. Shuai Lin 1#,
More informationHigh Expression of Forkhead Box Protein C2 is Related to Poor Prognosis in Human Gliomas
DOI:http://dx.doi.org/10.7314/APJCP.2014.15.24.10621 RESEARCH ARTICLE High Expression of Forkhead Box Protein C2 is Related to Poor Prognosis in Human Gliomas Yao-Wu Wang 1, Chun-Li Yin 2, Hong-Yi Zhang
More informationExpression of mir-146a-5p in patients with intracranial aneurysms and its association with prognosis
European Review for Medical and Pharmacological Sciences 2018; 22: 726-730 Expression of mir-146a-5p in patients with intracranial aneurysms and its association with prognosis H.-L. ZHANG 1, L. LI 2, C.-J.
More informationThe BCL11A-XL expression predicts relapse in squamous cell carcinoma and large cell carcinoma
Original Article The BCL11A-XL expression predicts relapse in squamous cell carcinoma and large cell carcinoma Na Zhang 1,2, Ben-Yuan Jiang 2, Xu-Chao Zhang 2, Zhi Xie 2, Jian Su 2, Qi Zhang 2, Jie-Fei
More informationThe Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (9), Page
The Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (9), Page 5298-5303 Prognostic Value of Platelet to Lymphocyte Ratio in Patients with Non-Small Cell Lung Cancer Mohammad Sabry Elkady, Ghada
More informationClinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma
Original Article Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma Zhaode Bu, Zhixue Zheng, Ziyu Li, Xiaojiang Wu, Lianhai Zhang, Aiwen Wu,
More informationSurvival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China Yu-Tao Liu, Xue-Zhi Hao, Jun-Ling Li, Xing-Sheng
More informationInternational association for the study of lung cancer/american thoracic society/european respiratory
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. William Travis, Elisabeth
More informationAssociation of mir-21 with esophageal cancer prognosis: a meta-analysis
Association of mir-21 with esophageal cancer prognosis: a meta-analysis S.-W. Wen 1, Y.-F. Zhang 1, Y. Li 1, Z.-X. Liu 2, H.-L. Lv 1, Z.-H. Li 1, Y.-Z. Xu 1, Y.-G. Zhu 1 and Z.-Q. Tian 1 1 Department of
More informationClinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during
Original Article Clinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during 2011 2015 Pingli Wang 1 *, Jixia Zou 1 *, Jingni Wu 1 *, Chengyan Zhang
More informationDownregulation of long non-coding RNA LINC01133 is predictive of poor prognosis in colorectal cancer patients
European Review for Medical and Pharmacological Sciences 2017; 21: 2103-2107 Downregulation of long non-coding RNA LINC01133 is predictive of poor prognosis in colorectal cancer patients J.-H. ZHANG 1,
More informationPrognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China
www.springerlink.com Chin J Cancer Res 23(4):265 270, 2011 265 Original Article Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai,
More informationPrudence Anne Russell 1,2, Gavin Michael Wright 3,4
Editorial Page 1 of 7 Predominant histologic subtype in lung adenocarcinoma predicts benefit from adjuvant chemotherapy in completely resected patients: discovery of a holy grail? Prudence Anne Russell
More informationThyroid transcription factor 1 (TTF1), a homeodomaincontaining
Original Article Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas Yiliang Zhang, MD,* Rui Wang, MD, PhD,* Yuan Li, MD, Yunjian Pan, MD,* Haichuan
More informationSteering Committee. Waiting on photo. Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD.
Steering Committee Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD MD, PhD Waiting on photo Paul Van Schil, MD, PhD William D. Travis, MD Ming-Sound Tsao,
More informationHypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients
Journal of BUON 17: 663-668, 2012 2012 Zerbinis Medical Publications. Printed in Greece ORIGINAL ARTICLE Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor
More informationRetrospective analysis of Gefitinib and Erlotinib in EGFR-mutated non-small-cell lung cancer patients
(2017) 1(1): 16-24 Mini Review Open Access Retrospective analysis of Gefitinib and Erlotinib in EGFR-mutated non-small-cell lung cancer patients Chao Pui I 1,3, Cheng Gregory 1, Zhang Lunqing 2, Lo Iek
More informationEGFR, Lung Cancer and Cytology. Maureen F. Zakowski, M.D. Lung cancer is one of the most lethal cancers in Western countries and in Japan.
EGFR, Lung Cancer and Cytology Maureen F. Zakowski, M.D. Lung cancer is one of the most lethal cancers in Western countries and in Japan. It is histopathologically divided into two major sub-groups: Small
More informationThe prognostic role of PRUNE2 in leiomyosarcoma
Chinese Journal of Cancer Original Article Lin-Ru Zhao 1,*, Wei Tian 1*, Guo-Wen Wang 1, Ke-Xin Chen and Ji-Long Yang 1,3 Abstract PRUNE plays an important role in regulating tumor cell differentiation,
More informationOriginal Article Expression of LRP16 in pancreatic ductal adenocarcinoma and its clinicopathological significance and prognostic value
Int J Clin Exp Pathol 2017;10(6):6918-6923 www.ijcep.com /ISSN:1936-2625/IJCEP0053602 Original Article Expression of LRP16 in pancreatic ductal adenocarcinoma and its clinicopathological significance and
More informationAssociation of BTBD7 with Metastasis and Poor Prognosis in Non-Small-Cell Lung Cancer Patients
477 Ivyspring International Publisher Research Paper Journal of Cancer 2015; 6(5): 477-481. doi: 10.7150/jca.11715 Association of BTBD7 with Metastasis and Poor Prognosis in Non-Small-Cell Lung Cancer
More informationOriginal Article Downregulation of microrna-26b functions as a potential prognostic marker for osteosarcoma
Int J Clin Exp Pathol 2016;9(6):6506-6510 www.ijcep.com /ISSN:1936-2625/IJCEP0024531 Original Article Downregulation of microrna-26b functions as a potential prognostic marker for osteosarcoma Zhihong
More informationExpression and Significance of GRP78 and HER-2 in Colorectal Cancer
Expression and Significance of GRP78 and HER-2 in Colorectal Cancer Qiu-xia Ji 1, Li-li Wang 2, Lin Li 3, Xiaoming Xing 2 1 Department of Pathology, Qingdao University, Qingdao, China 2 Department of Pathology,
More information